News Release

Blocking opioid receptors could reduce hormone-therapy-fueled increases in sugar intake

Findings of rat study suggest the opioid system is responsible for hormone treatment's effect on sugar consumption

Peer-Reviewed Publication

American Physiological Society

Orlando, Fla. (April 7, 2019)--Estradiol is a commonly prescribed estrogen therapy. Previous research has found that rats treated with the hormone experience an increase in sugar consumption. But according to new research, blocking the body's opioid receptors can reverse this effect. The findings will be presented today at the American Physiological Society's (APS) annual meeting at Experimental Biology 2019 in Orlando, Fla.

Estradiol is a naturally occurring estrogen hormone and common medication used in various hormone treatments, such as menopausal hormone therapy and birth control. Previous studies by this research team found giving estradiol replacement in a rat model of menopause caused the rats to consume more of an offered sugar solution.

Because the opioid system is known to contribute to overindulgence of highly palatable foods, the researchers decided to examine its role in estradiol's impact on sugar intake. Rats were assigned to either estradiol treatment or a control. Researchers then continuously infused rats with either naltrexone, which blocks opioid receptors, or saline. In a second experiment, the research team injected naltrexone or DAMGO, a synthetic compound that stimulates the opioid system, into an area of the brain associated with reward (the nucleus accumbens). In the first experiment, naltrexone treatment reversed the estradiol-related increase in sugar consumption. Injection of DAMGO stimulated sugar intake in both treated and control rats, but the effect was smaller in estradiol-treated rats than in control rats. These suggests that the opioid system plays a role in the estrogen-induced enhancement of sugar intake, but opioid receptors in the nucleus accumbens is not likely to be directly involved in the estrogen-induced enhancement of sugar intake.

Lead author Kurumi Iida noted that these findings suggest that extra sugar intake caused by estradiol "is possibly mediated by the opioid system." However, a potential site of the action for this phenomenon remains unknown.

Kurumi Iida, an undergraduate student at Nara Women's University in Nara, Japan, will present "Involvement of the opioid system in the 17β-estradiol-induced enhancement of sucrose intake in ovariectomized rats" Sunday, April 7, at a poster session in West Hall B of the exhibit hall of the Orange County Convention Center.

###

NOTE TO JOURNALISTS: To schedule an interview with a member of the research team, please contact the APS Communications Office or 301-634-7209. Find more research highlights in the APS Press Room.

About Experimental Biology 2019

Experimental Biology is an annual meeting comprised of more than 14,000 scientists and exhibitors from five sponsoring societies and multiple guest societies. With a mission to share the newest scientific concepts and research findings shaping clinical advances, the meeting offers an unparalleled opportunity for exchange among scientists from across the United States and the world who represent dozens of scientific areas, from laboratory to translational to clinical research.

Physiology is the study of how molecules, cells, tissues and organs function in health and disease. Established in 1887, the American Physiological Society (APS) was the first U.S. society in the biomedical sciences field. The Society represents more than 10,000 members and publishes 15 peer-reviewed journals with a worldwide readership.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.